The'America's Got Talent' judge told Fox News Digital why he doesn't like AI technology in songwriting. "Rocky IV" star Dolph Lundgren is looking forward to seeing artificial intelligence used in the medical field. "AI I'm sure will be extremely useful," Lundgren told Fox News Digital. He continued, "They used it to find that COVID vaccine so quickly. And they've actually taken those same algorithms and used it in cancer research [I know] because I'm a little bit involved in that now. Earlier this year, CNBC reported that Moderna had partnered with IBM to use generative AI and quantum computing to advance mRNA technology, a key component in the company's COVID-19 vaccine. The agreement could help speed up Moderna's work on new vaccines and therapies. Last month, Insilico Medicine, an AI-driven biotech company based in Hong Kong and New York City, recently announced that its new AI-designed drug for COVID-19 has entered Phase I clinical trials, and could become an alternative to current antivirals like Paxlovid and Lagevrio. WHAT IS ARTIFICIAL INTELLIGENCE (AI)? Dolph Lundgren hopes AI "will be extremely useful" when it comes to cancer research. Lundgren has been battling cancer since 2015 after doctors found a tumor in his kidney. He underwent surgery and was doing well until 2020, when additional tumors were discovered. In 2021, he was told one tumor had grown to the "size of a lemon" and was inoperable, but he later sought a second opinion, and alternative treatments were made available to the actor. Lundgren told Fox News Digital that he is now doing well, though still facing a somewhat tough road. "Last time I checked, you know, everything was good," he said. "There is no cancer, and they check the blood for cancer cells." Dolph Lundgren told Fox News Digital that he is doing well with his cancer treatments and lives "a normal life now." He continued, "I think I'll always have to be on some kind of treatment and be aware of this, but I live a normal life now.

Fox News Flash top entertainment and celebrity headlines are here. Check out what's clicking today in entertainment. Sylvester Stallone isn't finished with the "Rocky" franchise just yet. On Sunday, the 74-year-old actor took to Instagram to announce that a director's cut of the film "Rocky IV" is on the way. He shared the news alongside a painted image from the film featuring his own character, Rocky Balboa, and Dolph Lundgren's Ivan Drago who has the famous line: "If he dies, he dies." "For the 35th anniversary Rocky 4 Is getting a new DIRECTORS cut by me," Stallone announced.

To map every gene in the human body, scientists around the world collaborated for more than a decade, from 1990 to 2003. Thanks to their work, entire vistas of medicine have opened up, from new diagnoses to drug regimens tailored to an individual's genetic makeup. What if, posits Dorn Cox, a produce farmer in New Hampshire, the same could be done for the world's soil? With detailed knowledge of the nutrients in their soil, farmers could better tend their dirt and significantly reduce negative environmental impacts. For example, they could better learn what to plant and when, or how to maximize soil nutrients and track carbon content (more carbon in the soil means less carbon in the atmosphere).

Quantemplate, a startup providing self-service, cloud-based automated data solutions for insurers and reinsurers, today revealed that it raised over $12 million in a recent funding round led by Route 66 Ventures and Transamerica Ventures, with participation from Anthemis Group, Allianz X, and Insight Catastrophe Group. The raise brings the New York- and London-based company's total raised to over $25 million, which CEO David Lundgren said will fuel R&D and customer acquisition as Quantemplate grows its global sales and marketing teams. Coinciding with the capital infusion, Quantemplate also announced the general availability of its platform. "With this recently secured round of funding, Quantemplate is primed and ready to present our proven technology to the [insurance and reinsurance] industry. We are eager to provide the unique tools and insights customers need to make business processes more efficient, while at the same time appreciating a more comprehensive assessment of risk," said Lundgren.